Walboomers J, Jacobs M, Manos M, Bosch X, Kummer A, Shah K, Snijders P, Peto J, Meijer C, Muñoz N: Human Papilloma Virus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999, 189: 12-19. 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F.
Article
CAS
PubMed
Google Scholar
Bosch X, Muñoz N: The viral etiology of cervical cancer. Virus Res. 2002, 89: 183-190. 10.1016/S0168-1702(02)00187-9.
Article
CAS
PubMed
Google Scholar
Münger K, Howley P: Human papillomavirus immortalization and transforming functions. Virus Res. 2002, 89: 213-228. 10.1016/S0168-1702(02)00190-9.
Article
PubMed
Google Scholar
Ried T, Hesselmeyer K, Blegen H, Schröck E, Auer G: Genomic changes defining the genesis, progression and malignancy in solid human tumors: a phenotype/genotype correlation. Genes Chrom Cancer. 1999, 25: 195-204. 10.1002/(SICI)1098-2264(199907)25:3<195::AID-GCC1>3.0.CO;2-8.
Article
CAS
PubMed
Google Scholar
Pihan G, Wallace J, Zhou Y, Doxsey S: Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. Cancer Res. 2003, 63: 1398-1404.
CAS
PubMed
Google Scholar
Cahill DP, Kinzler KW, Vogelstein B, Lengauer C: Genetic instability and darwinian selection in tumours. Trends Cell Biol. 1999, 9: M57-M60. 10.1016/S0962-8924(99)01661-X.
Article
CAS
PubMed
Google Scholar
Heselmeyer K, Schröck E, Du Manoir S, Blegen H, Shah K, Steinbeck R, Auer G, Ried T: Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci USA. 1996, 93: 479-484. 10.1073/pnas.93.1.479.
Article
CAS
PubMed
PubMed Central
Google Scholar
Heselmeyer K, Macville M, Schröck E, Blegen H, Hellström A, Shah K, Auer G, Ried T: Advanced stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q. Genes Chrom Cancer. 1997, 19: 233-240. 10.1002/(SICI)1098-2264(199708)19:4<233::AID-GCC5>3.0.CO;2-Y.
Article
CAS
PubMed
Google Scholar
Dellas A, Torhorst J, Jiang F, Proffit J, Schultheiss E, Holzgreve W, Sauter G, Mihatsch M, Moch H: Prognostic value of genomic alterations in invasive cervical squamous cell carcinoma stage IB detected by comparative genomic hybridization. Cancer Res. 1999, 59: 3475-3479.
CAS
PubMed
Google Scholar
Kirchhoff M, Rose H, Petersen B, Maahr J, Gerdes T, Lundsteen C, Bryndorf T, Kryger-Baggesen N, Christensen L, Engelholm S, Philip J: Comparative genomic hybridization reveals a recurrent pattern of chromosomal aberrations in severe dysplasia/carcinoma in situ of the cervix and in advanced-stage cervical carcinoma. Genes Chrom Cancer. 1999, 24: 144-150. 10.1002/(SICI)1098-2264(199902)24:2<144::AID-GCC7>3.0.CO;2-9.
Article
CAS
PubMed
Google Scholar
Allen D, White D, Hutchins A, Scurry J, Tabrizi S, Garland S, Armes J: Progressive genetic aberrations detected by comparative genomic hybridization in squamous cell carvical cancer. Br J Cancer. 2000, 83: 1659-1663. 10.1054/bjoc.2000.1509.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kirchhoff M, Rose H, Petersen B, Maahr J, Gerdes T, Philip J, Lundsteen C: Comparative genomic hybridization reveals non-random chromosomal aberrations in early preinvasive cervical lessions. Cancer Genet Cytogenet. 2001, 129: 47-51. 10.1016/S0165-4608(01)00424-1.
Article
CAS
PubMed
Google Scholar
Umayahara K, Numa F, Suehiro Y, Sakata A, Nawata S, Ogata H, Suminami Y, Sakamoto M, Sasaki K, Kato H: Comparative Genomic Hybridization detects genetic alterations during early stages of cervical cancer progression. Genes Chrom Cancer. 2002, 33: 98-102. 10.1002/gcc.1215.
Article
CAS
PubMed
Google Scholar
Harris CP, Lu XY, Narayan G, Singh B, Murty VV, Rao PH: Comprehensive molecular cytogenetic characterization of cervical cancer cell lines. Genes Chrom Cancer. 2003, 36: 233-241. 10.1002/gcc.10158.
Article
CAS
PubMed
Google Scholar
Narayan G, Pulido HA, Koul S, Lu XY, Harris CP, Yeh YA, Vargas H, Posso H, Terry MB, Gissmann L, Schneider A, Mansukhani M, et al: Genetic analysis identifies putative tumor supressor sites at 2q35-q36.1 and 2q36.3-q37.1 involved in cervical cancer progression. Oncogene. 2003, 22: 3489-3499. 10.1038/sj.onc.1206432.
Article
CAS
PubMed
Google Scholar
Rao PH, Arias-Pulido H, Lu XY, Harris CP, Vargas H, Zhang FF, Narayan G, Schneider A, Terry MB, Murty VV: Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma. BMC Cancer. 2004, 4: 5-10.1186/1471-2407-4-5.
Article
PubMed
PubMed Central
Google Scholar
Solinas-Toldo S, Dürst M, Lichter P: Specific chromosomal imbalances in human papillomavirus transfected cells during progression toward immortality. Proc Natl Acad Sci USA. 1997, 94: 3854-3859. 10.1073/pnas.94.8.3854.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hidalgo A, Schewe C, Petersen S, Salcedo M, Gariglio P, Schlüns K, Dietel M, Petersen I: Human papilloma virus status and chromosomal imbalances in primary cervical carcinomas and tumor cell lines. Eur J Cancer. 2000, 36: 542-548. 10.1016/S0959-8049(99)00323-8.
Article
CAS
PubMed
Google Scholar
Hidalgo A, Monroy A, Arana R, Taja L, Vázquez G, Salcedo M: Chromosomal imbalances in four new uterine cervix carcinoma derived cell lines. BMC Cancer. 2003, 3 (1): 8-10.1186/1471-2407-3-8.
Article
PubMed
PubMed Central
Google Scholar
Lichter P, Joos S, Bentz M, Lampel S: Comparative genomic hybridization: uses and limitations. Semin Hematol. 2000, 37: 348-357. 10.1053/shem.2000.16594.
Article
CAS
PubMed
Google Scholar
Solinas-Toldo S, Lampel S, Stilgenbauer S, Nickolenko J, Benner A, Dohner H, Cremer T, Lichter P: Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chrom Cancer. 1997, 20: 399-407. 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I.
Article
CAS
PubMed
Google Scholar
Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, Collins C, Kuo WL, Chen C, Zhai Y, Dairkee SH, Ljung BM, et al: High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nature Genet. 1998, 20: 207-211. 10.1038/2524.
Article
CAS
PubMed
Google Scholar
Pollack JR, Perou CM, Alizadeh AA, Eisen MB, Pergamenschikov A, Williams CF, Jeffrey SS, Botstein D, Brown PO: Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nature Genet. 1999, 23: 41-46. 10.1038/14385.
Article
CAS
PubMed
Google Scholar
Caceres-Cortes JR, Alvarado-Moreno JA, Waga K, Rangel-Corona R, Monroy-Garcia A, Rocha-Zavaleta L, Urdiales-Ramos J, Weiss-Steider B, Haman A, Hugo P, Brousseau R, Hoang T: Implication of tyrosine kinase receptor and steel factor in cell density-dependent growth in cervical cancer and leukemias. Cancer Res. 2001, 61: 6281-6289.
CAS
PubMed
Google Scholar
Baudis M, Cleary ML: Progenetix.net: an online repository for molecular cytogenetic aberration data. Bioinformatics. 2001, 17: 1228-1229. 10.1093/bioinformatics/17.12.1228.
Article
CAS
PubMed
Google Scholar
Giarnieri E, Mancini R, Pisani T, Alderisio M, Vecchione A: Msh2, Mlh1, Fhit, p53, Bcl-2, and Bax expression in invasive and in situ squamous cell carcinoma of the uterine cervix. Clin Cancer Res. 2000, 6: 3600-3606.
CAS
PubMed
Google Scholar
Kwasniewska A, Gozdzicka-Jozefiak A, Postawski K, Miturski R: Evaluation of DNA mismatch repair system in cervical dysplasias and invasive carcinomas related to HPV infection. Eur J Gynaecol Oncol. 2002, 23: 231-235.
CAS
PubMed
Google Scholar
Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT, Tabin C, Sharpe A, Caput D, Crum C, McKeon F: p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature. 1999, 398: 714-718. 10.1038/19539.
Article
CAS
PubMed
Google Scholar
Quade BJ, Yang A, Wang Y, Sun D, Park J, Sheets EE, Cviko A, Federschneider JM, Peters R, McKeon FD, Crum CP: Expression of the p53 homologue p63 in early cervical neoplasia. Gynecol Oncol. 2001, 80: 24-29. 10.1006/gyno.2000.5953.
Article
CAS
PubMed
Google Scholar
Wang T, Chen B, Yang Y, Chen H, Wang Y, Cviko A, Quade B, Sun D, Yang A, Mckeon F, Crum C: Histologic and immunophenotypic classification of cervical carcinomas by expression of the p53 homologue p63: A study of 250 cases. Hum Pathol. 2001, 32: 479-486. 10.1053/hupa.2001.24324.
Article
CAS
PubMed
Google Scholar
Cho NH, Kim YB, Park TK, Kim GE, Park K, Song KJ: P63 and EGFR as prognostic predictors in stage IIB radiation-treated cervical squamous cell carcinoma. Gynecol Oncol. 2003, 91: 346-353. 10.1016/S0090-8258(03)00504-3.
Article
CAS
PubMed
Google Scholar
Chen H, Toyooka S, Gazdar AF, Hsieh JT: Epigenetic regulation of a novel tumor suppressor gene (hDAB2IP) in prostate cancer cell lines. J Biol Chem. 2003, 278: 3121-3130. 10.1074/jbc.M208230200.
Article
CAS
PubMed
Google Scholar
Yang DH, Smith ER, Cohen C, Wu H, Patriotis C, Godwin AK, Hamilton TC, Xu XX: Molecular events associated with dysplastic morphologic transformation and initiation of ovarian tumorigenicity. Cancer. 2002, 94: 2380-2392. 10.1002/cncr.10497.
Article
CAS
PubMed
Google Scholar
Sheng Z, Sun W, Smith E, Cohen C, Sheng Z, Xu XX: Restoration of positioning control following Disabled-2 expression in ovarian and breast tumor cells. Oncogene. 2000, 19: 4847-4854. 10.1038/sj.onc.1203853.
Article
CAS
PubMed
Google Scholar
Huang LW, Chao SL, Chen TJ: Reduced Fhit expression in cervical carcinoma: correlation with tumor progression and poor prognosis. Gynecol Oncol. 2003, 90: 331-337. 10.1016/S0090-8258(03)00318-4.
Article
CAS
PubMed
Google Scholar
Butler D, Collins C, Mabruk M, Leader MB, Kay EW: Loss of Fhit expression as a potential marker of malignant progression in preinvasive squamous cervical cancer. Gynecol Oncol. 2002, 86: 144-149. 10.1006/gyno.2002.6712.
Article
CAS
PubMed
Google Scholar
Takizawa S, Nakagawa S, Nakagawa K, Yasugi T, Fujii T, Kugu K, Yano T, Yoshikawa H, Taketani Y: Abnormal Fhit expression is an independent poor prognostic factor for cervical cancer. Br J Cancer. 2003, 88: 1213-1216. 10.1038/sj.bjc.6600892.
Article
CAS
PubMed
PubMed Central
Google Scholar
Thorland EC, Myers SL, Gostout BS, Smith DI: Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene. 2003, 22: 1225-1237. 10.1038/sj.onc.1206170.
Article
CAS
PubMed
Google Scholar